In a statement Vitesco‘s Chief Executive Andreas Wolf said, the company had received a $2.20 billion (2 billion euros) order to produce a component for electric vehicles (EVs). Wolf did not name the client. Last year the company had forecast… Read More ›
Johnson & Johnson expects an increase in demand for its cancer drugs. On Tuesday, Johnson & Johnson first quarterly report beat analysts’ estimate and raised its full-year sales forecast on the strength of a growing demand for its cancer drugs…. Read More ›
manageria.biz 